Morphosys (OTCMKTS:MPSYY) Stock Price, News, Analysis & History

$51.70 -2.30 (-4.26 %)
(As of 03/23/2018 04:00 PM ET)
Previous Close$51.70
Today's Range$51.40 - $52.00
52-Week Range$27.34 - $54.00
Volume1,573 shs
Average Volume763 shs
Market Capitalization$2.97 billion
P/E RatioN/A
Dividend YieldN/A

About Morphosys (OTCMKTS:MPSYY)

MorphoSys AG develops and commercializes antibodies for therapeutic applications. The Company develops drugs using its own research and development, as well as in cooperation with pharmaceutical and biotechnology partners. The Company's operating segments include Proprietary Development and Partnered Discovery. In the Proprietary Development segment, it develops therapeutic antibodies and peptides in the area of inflammatory disease and oncology. In the Partnered Discovery segment, the Company applies technologies for the research, development and optimization of therapeutic antibodies as drug candidates. The Company develops new treatments for patients suffering from serious diseases. Its technologies include HuCAL, which is a collection fully human antibodies and a system for their optimization; Ylanthia, which is an antibody library in Fab format, and Slonomics, an automated technology for gene synthesis and modification for the generation of gene libraries in a controlled process.

Receive MPSYY News and Ratings via Email

Sign-up to receive the latest news and ratings for MPSYY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding Shares1

Morphosys (OTCMKTS:MPSYY) Frequently Asked Questions

What is Morphosys' stock symbol?

Morphosys trades on the OTCMKTS under the ticker symbol "MPSYY."

Who are some of Morphosys' key competitors?

Who are Morphosys' key executives?

Morphosys' management team includes the folowing people:

  • Gerald Moeller, Chairman of the Supervisory Board
  • Simon E. Moroney Ph.D., Member of the Management Board, Chief Executive Officer
  • Jens Holstein, Chief Financial Officer, Member of the Management Board
  • Markus Enzelberger, Chief Scientific Officer, Member of the Management Board
  • Anke Linnartz, Vice President and Head of Corporate Communications and Investor Relations
  • Malte Peters, Chief Development Officer , Member of the Management Board
  • Marc Cluzel M.D., Ph.D., Member of the Supervisory Board (Age 57)
  • Karin Eastham CPA, Member of the Supervisory Board (Age 67)
  • Wendy Johnson, Member of the Supervisory Board
  • Klaus Kuehn, Member of the Supervisory Board

Has Morphosys been receiving favorable news coverage?

News stories about MPSYY stock have been trending positive this week, according to Accern Sentiment. Accern rates the sentiment of media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Morphosys earned a news impact score of 0.38 on Accern's scale. They also gave media coverage about the company an impact score of 46.08 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term.

How do I buy shares of Morphosys?

Shares of MPSYY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Morphosys' stock price today?

One share of MPSYY stock can currently be purchased for approximately $51.70.

How big of a company is Morphosys?

Morphosys has a market capitalization of $2.97 billion.

How can I contact Morphosys?

Morphosys' mailing address is Semmelweisstr. 7, PLANEGG, 82152, Germany. The company can be reached via phone at +49-89-899270.

MarketBeat Community Rating for Morphosys (MPSYY)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  17 (Vote Outperform)
Underperform Votes:  17 (Vote Underperform)
Total Votes:  34
MarketBeat's community ratings are surveys of what our community members think about Morphosys and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Morphosys (OTCMKTS:MPSYY) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Morphosys (OTCMKTS:MPSYY) Consensus Price Target History

Price Target History for Morphosys (OTCMKTS:MPSYY)

Morphosys (OTCMKTS:MPSYY) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
10/6/2017JPMorgan Chase & Co.UpgradeNeutral -> OverweightView Rating Details
(Data available from 3/24/2016 forward)


Earnings History for Morphosys (OTCMKTS:MPSYY)

No earnings announcements for this company have been tracked by


Morphosys (OTCMKTS:MPSYY) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for Morphosys (OTCMKTS:MPSYY)

No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Morphosys (OTCMKTS MPSYY)

No insider trades for this company have been tracked by


Morphosys (OTCMKTS MPSYY) News Headlines


SEC Filings

Morphosys (OTCMKTS:MPSYY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


Morphosys (OTCMKTS MPSYY) Stock Chart for Saturday, March, 24, 2018

Loading chart…

This page was last updated on 3/24/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.